tirzepatide and glp 1 💊 GLP-1 Spotlight: Semaglutide vs Both medications are powerful options for weight management—but they work a little differently. ✨ Semaglutide → Acts on GLP-1 receptors to regulate appetite, slow digestion, GLP-1 vs. GLP-1 + GIP:

During treatment , contact your GP if you experience: Persistent gastrointestinal symptoms such as severe nausea, vomiting, or diarrhoea, which may affect the absorption of thyroid medication or lead to dehydration

All drugs were prepared preserving more than 1 year under given conditions avoiding degradation

It filled a genuine gap when GLP-1s were impossible to find, and it continues to serve patients with needs that FDA-approved medications cant meet

The optional intermediate doses (7.5 mg, 12.5 mg) also make tirzepatide more adaptable

The SURMOUNT-1 trial showed that tirzepatide produces dose-dependent weight reduction of 15% to 22.5% over 72 weeks in patients with obesity